Are you looking for the best penny stocks to buy in February 2023? If so, you’ve come to the right place. In this article, we’ll take a look at four penny stocks that have been turning heads on Wall Street. These stocks are PolyPid Ltd. (NASDAQ:PYPD), Eaton Pharmaceuticals (NASDAQ:ETON), Aprea Therapeutics Inc. (NASDAQ:APRE), and Fresh Tracks Therapeutics (NASDAQ:FRTX).
PolyPid Ltd. (NASDAQ:PYPD) is a clinical-stage biotechnology company that is focused on developing novel treatments for patients with serious infections. The company’s two core platforms, UltraCAR-T and UltraCAR-B, have the potential to revolutionize the treatment of antibiotic-resistant infections. Wall Street analysts are expecting big things from PolyPid in 2023, especially after the company announced that it had raised $50 million in a private placement.
Eaton Pharmaceuticals (NASDAQ:ETON) is a specialty pharmaceutical company that develops and manufactures generic and branded drugs. The company’s pipeline of products includes products for the treatment of asthma, diabetes, and cardiovascular diseases. The company is also working on a number of promising new products, including a generic version of Lantus, which is a long-acting insulin product.